| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
MDxHealth (NASDAQ:MDXH) is gearing up to announce its quarterly earnings on Thursday, 2025-08-14. Here's a quick overview of what investors should know before the release.
Analysts are estimating that MDxHealth will report an earnings per share (EPS) of $-0.04.
The market awaits MDxHealth's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
During the last quarter, the company reported an EPS missed by $0.06, leading to a 6.74% increase in the share price on the subsequent day.
Here's a look at MDxHealth's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.13 | -0.20 | -0.27 | -0.26 |
| EPS Actual | -0.19 | -0.14 | -0.40 | -0.42 |
| Price Change % | 7.000000000000001% | 2.0% | 0.0% | -12.0% |
Shares of MDxHealth were trading at $2.87 as of August 12. Over the last 52-week period, shares are down 2.25%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for MDxHealth visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: MDXH
